Use of Cardiovascular Medications in the Study Population.
Treatment rates for aspirin, statin, beta-blocker, angiotensin-converting enzyme inhibitor (ACEi) and/or angiotensin receptor blocker (ARB) and diuretics according to the presence or absence of myocardial infarction (MI)—unrecognized myocardial infarction (UMI) or recognized myocardial infarction (RMI). N = 2,349.